Faculty

Mark L. Kahn, M.D.

faculty photo
Edward S. Cooper, M.D./Norman Roosevelt and Elizabeth Meriwether McLure Professor
Department: Medicine

Contact information
11-123 Smilow Center for Translational Research
3400 Civic Center Boulevard, Bldg. 421
Philadelphia, PA 19104-5159
Office: (215) 898-9007
Fax: (215) 573-2094
Education
B.A. (Biology)
Brown University, 1984.
M.D. (Medicine)
Brown University School of Medicine, 1987.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Research Interests
Signaling pathways in angiogenesis and hemostasis.

Key words: Angiogenesis, vascular development, platelet, signaling.

Description of Research
My laboratory investigates signaling pathways in cardiovascular development and function. We have two general areas of interest: angiogenesis and platelet signaling. In some cases these areas intersect, e.g. the role of Syk and SLP-76 signaling downstream of platelet receptors that regulate lymphatic vascular development. Major projects in the lab include the following: Regulation of lymphatic vascular development by Syk and SLP-76 signaling. Mice lacking Syk or SLP-76 exhibit lethal vascular phenotypes that we have recently found to be due to a failure to separate emerging lymphatic vessels from pre-existing blood vessels. We have recently identified platelet interaction with lymphatic endothelial cells as the basis for this mechanism of vascular regulation. The long term goals of this project are to understand how platelets control endothelial function and lymphatic vascular development. Platelet immunoreceptor signaling. There are two platelet-specific immune-type receptors, GPVI and CLEC2, that activate Syk and SLP-76 signals. GPVI is a collagen receptor that functions in hemostasis and thrombosis. CLEC2 is a receptor for the lymphatic endothelial protein PDPN and regulates blood-lymphatic vascular interactions. We are presently using mouse genetic models to understand how these two receptors signal and to define their biological roles in vivo. Role of cerebral cavernous malformation (CCM) signaling pathway in vascular development and disease. CCMs are a common human vascular disease caused by loss of function mutations in 3 CCM proteins. We have recently shown that the Heart of Glass (HEG) receptor and CCM proteins are required in mouse and fish cardiovascular development. We are actively investigating how this recently identified pathway regulates endothelial function in development and causes CCMs.

Rotation Projects
1. Regulation of lymphatic vascular development by platelet signaling. 2. HEG-CCM signaling in fish and mouse models. 3. Novel receptor signaling pathways in mammalian cardiovascular development. 4. Development and application of lymphatic endothelial-specific gene knockouts.

Lab personnel:
Xiangjain Zheng, PhD-postdoctoral fellow; Zhiyng Zou, PhD-postdoctoral fellow; Cara Bertozzi, PhD student; Chiu-Yu Chen, MD-PhD student; Alec Schmaier, PhD student; Chong Xu, PhD-postdoctoral fellow; Jiping Xiao, PhD-postdoctoral fellow; Patricia Mericko, Lab Manager; Mei Chen Research, Specialist.

Description of Clinical Expertise

general cardiology

Selected Publications

Frankfurter MT, Tang AT, Zhang Z, Yang J, Narayan S, Nguyen E, Li L, Mericko-Ishizuka P, Chen M, Dahlgren AR, Senis YA, Traynelis SF, Outtz Reed H, Shavit JA, Kahn ML: The thrombin receptor PAR1 is activated during mouse megakaryopoiesis. Blood Adv Oct 2026.

Bandla S, Montoya Rush MN, Ghosh S, Suresh S, Jain A, Puri V, Welsh JD, Kahn ML, Marklin G, Leonard JM, Niziolek GM, Turnbull IR, Hoofnagle MH: Restoration of oscillatory shear stress in humans activates an endothelial protective genetic program and prevents DVT. Blood Aug 2026.

Li L, Lightle R, Ali B, Sader G, Shenkar R, Polster SP, Marchuk DA, Burkhardt JK, Awad IA, Kahn ML: Growth of PIK3CA-driven cerebral cavernous malformations does not require microbiome stimulation. JCI Insight Jul 2026.

Dominguez VH, Frankfurter M, Hayes KB, Kahn ML, Dominguez MH: A portable, ultra-low cost, open-source, pedal-controlled microinjector for laboratory use. PLoS One May 2026.

Li L, Castro M, Hongo H, Ren J, Shenkar R, Jabarkheel R, Gao S, Narayan S, Frankfurter M, Tang AT, Yang J, Chen M, Bockman J, Mericko-Ishizuka P, Alcazar R, Sader G, Iqbal J, Kinkade S, Lightle R, Ressler AK, Qu X, Baldwin HS, Marchuk DA, Awad IA, Burkhardt JK, Potente M, Kahn ML: TIE2 links MEKK3-KLF2/4 and PI3K signaling in cerebral cavernous malformation. J Exp Med Mar 2026.

Sung DC, Ahanger HA, Narayan S, Pace JA, Chen M, Yang J, Gao S, Keller TCS 4th, Bockman J, Chen X, Nguyen E, Tang AT, Mericko-Ishizuka P, Maillard I, Kahn ML: Dll4 assembles the umbilical cord and placental vasculature. JCI Insight Feb 2026.

Bovay E, Kruse K, Watson EC, Mohanakrishnan V, Stehling M, Berkenfeld F, Pitulescu ME, Kahn ML, Adams RH: Artery formation in the intestinal wall and mesentery by intestine-derived Esm1+ endothelial cells. Nat Commun Sep 2025.

Pace JA, Goddard LM, Hong CC, Wang L, Yang J, Chen M, Xu Y, Dominguez MH, Gao S, Chen X, Mericko-Ishizuka P, Tan C, Kume T, Yu W, Tan K, Hancock WW, Ferrari G, Kahn ML: Hemodynamic forces prevent myxomatous valve disease in mice through KLF2/4 signaling. J Clin Invest Jun 2025.

Chen X, Tober J, Dominguez M, Tang AT, Bockman J, Yang J, Mani S, Lee CN, Chen M, Thillaikumaran T, Mericko-Ishizuka P, Mainigi M, Speck NA, Kahn ML: Lineage tracing studies suggest that the placenta is not a de novo source of hematopoietic stem cells. PLoS Biol Jan 2025.

Jabarkheel R, Li L, Frankfurter M, Zhang DY, Gajjar A, Muhammad N, Srinivasan VM, Burkhardt JK, Kahn M: Untangling sporadic brain arteriovenous malformations: towards targeting the KRAS/MAPK pathway. Front Surg. Dec 2024.

back to top
Last updated: 10/13/2026
The Trustees of the University of Pennsylvania